Nomura Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Sell |
|
|||||
|
2025
Q1 | $193K | Sell |
|
|||||
|
2024
Q4 | $2.9M | Buy |
|
|||||
|
2024
Q3 | $3.07M | Buy |
|
|||||
|
2024
Q2 | $2.83M | Buy |
|
|||||
|
2024
Q1 | $3.68M | Sell |
|
|||||
|
2023
Q4 | $3.23M | Buy |
|
|||||
|
2023
Q3 | $2.43M | Sell |
|
|||||
|
2023
Q2 | $2.62M | Sell |
|
|||||
|
2023
Q1 | $2.59M | Buy |
|
|||||
|
2022
Q4 | $2.6M | Buy |
|
|||||
|
2022
Q3 | $2.34M | Buy |
|
|||||
|
2022
Q2 | $2.36M | Buy |
|
|||||
|
2022
Q1 | $3.12M | Buy |
|
|||||
|
2021
Q4 | $3.89M | Buy |
|
|||||
|
2021
Q3 | $4.17M | Buy |
|
|||||
|
2021
Q2 | $3.52M | Buy |
|